JBIO
Jade Biosciences, Inc.
NASDAQ: JBIO · HEALTHCARE · BIOTECHNOLOGY
$24.40
+9.32% today
Updated 2026-04-30
Market cap
$1.32B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.19
Dividend yield
—
52W range
$7 – $28
Volume
0.6M
Jade Biosciences, Inc. (JBIO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-89.20%
ROA
-33.60%
Debt/equity
0.00x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | — | $-9.61M | — | — | — |
| 2021 | — | $-22.96M | — | — | — |
| 2022 | — | $-51.51M | — | — | — |
| 2023 | — | $-75.52M | — | — | — |
| 2024 | — | $-69.63M | — | — | — |
| 2025 | $0.00 | $-127.41M | — | — | — |